CUX1 stabilizes Src and in turn activates its downstream signaling molecules such as RhoA, Rac1, Cdc42, and ROCK by transcriptionally upregulating C-terminal Src kinase (Csk) in pancreatic cancer (76). Here, CSK is linked to pancreatic neoplasm.